LAST CHANCE TO REGISTER:
Join us tomorrow to discuss going beyond vaccines and how we are ‘Harnessing AI to Accelerate Undiscovered Treatment for COVID19’. Wednesday 3 March 202111am- 1pm ESTREGISTER HERE: https://lnkd.in/eB8G2j4 With guest speakers:Michal Linial, PhD | The Hebrew University of JerusalemCoronavirus Cell Entry: Seeking The Achilles’ Heel Dr Ariel Rokach | Shaare Zedek Medical Center, JerusalemCOVID19 Is One Year Old […]
It’s time to discuss drug discovery for COVID19 beyond vaccines. Join us for this webinar to find out more about ‘Harnessing AI to Accelerate Undiscovered Treatment for COVID19.’
Wednesday 3 March 202111am- 1pm EST With guest speakers:Michal Linial, PhD | The Hebrew University of JerusalemCoronavirus Cell Entry: Seeking The Achilles’ Heel Dr Ariel Rokach | Shaare Zedek Medical CenterCOVID19 Is One Year Old – What We Have Learned – Insights & Thoughts Immanuel Lerner, Ph.D. | Pepticom Ltd.Harnessing AI Technology For Peptide – Based Drug Discovery […]
#55 of 100 innovative Israeli startups = Pepticom.
Never has there been a time in our lives where drug discovery and time-to-market has been more prevalent than right now! So it is exciting to see Pepticom being recognized for our technology which harnesses AI to accelerate drug discovery and dramatically reduce drug development costs. Exciting times. Darren Gladstone covers more in his 2Scots – Marketing […]
Pepticom is participating in the BioDigital conference this week.
If you are interested to learn more on Pepticom’s AI peptide design & discovery technology, please contact Shoshi.Keynan@wordpress-544837-1818586.cloudwaysapps.com
Pepticom is fighting the corona virus
In the news: https://www.kan.org.il/Item/?itemId=69208
Pepticom is implementing its proprietary technology on various SARS-CoV-2 proteins and the ACE2
to identify novel inhibitors that can fight the COVID19. We are looking for partners to validate and develop these peptide drug candidates. For more information: maayan.elias@wordpress-544837-1818586.cloudwaysapps.com
Partner with us to fight the Corona virus!
https://www.israel21c.org/30-israeli-medical-tech-solutions-to-help-fight-coronavirus/ For more information : Shoshi.Keynan@wordpress-544837-1818586.cloudwaysapps.com
Dr. Shoshi Keynan , Pepticom’s VP BD will be attending BioEurope on March 23-25 in Paris.
Meet us and learn how Pepticom’s AI peptide design platform can augment your drug discovery process. For more information: shoshi.keynan@wordpress-544837-1818586.cloudwaysapps.com
Pepticom’s AI peptide design platform as part of “Lead Identification” in the drug discovery ecosystem
https://www.biopharmatrend.com/m/map/
Dr. Immanuel Lerner, Pepticom’s CEO, will present at “DISCOVERY on TARGET” Conference in Boston (September 25-28).
Dr. Lerner will discuss Pepticom’s exciting design work on TLR4 activators in “the Cyclic Peptide Design Challenges” session.